Achilles tendon thickening is associated with disease severity and plaque vulnerability in patients with coronary artery disease.


Journal

Journal of clinical lipidology
ISSN: 1933-2874
Titre abrégé: J Clin Lipidol
Pays: United States
ID NLM: 101300157

Informations de publication

Date de publication:
Historique:
received: 26 05 2018
revised: 19 10 2018
accepted: 19 10 2018
pubmed: 26 11 2018
medline: 6 5 2020
entrez: 26 11 2018
Statut: ppublish

Résumé

Tendon xanthomas are accumulations of collagen and macrophages, which contain cholesterol esters and a marker of high risk for coronary artery disease (CAD). The aim of the article was to clarify whether the presence of Achilles tendon thickening (ATT) was associated with disease severity and plaque vulnerability in patients with CAD. A total of 241 consecutive patients who underwent percutaneous coronary intervention and ATT assessment were analyzed. ATT was defined as Achilles tendon thickness of ≥9 mm on radiograph. The severity of CAD and plaque vulnerability was assessed by the findings on angiogram and optical coherence tomography, respectively. ATT was found in 44 patients (18.2%). The frequency of multivessel disease (79.6% vs 58.4%, P = .009) and left main lesion (13.6% vs 3.1%, P = .004) was significantly higher in patients with ATT (ATT group) than in patients without ATT (no ATT group). Multivariate logistic regression analyses demonstrated that the presence of ATT was independently associated with the presence of multivessel disease (odds ratio, 2.33; 95% confidence interval, 1.08-5.46; P = .031). The ATT group had a higher prevalence of intimal vascular channels (50.0% vs 24.7%, P = .018) and macrophage accumulation (58.3% vs 33.3%, P = .028) in culprit plaque than the no ATT group. Patients with the presence of ATT had a higher prevalence of multivessel coronary disease and left main coronary artery disease than with patients without ATT. The presence of ATT was also associated with vulnerable features, including intimal vascular channels and macrophage accumulation in culprit plaques.

Sections du résumé

BACKGROUND
Tendon xanthomas are accumulations of collagen and macrophages, which contain cholesterol esters and a marker of high risk for coronary artery disease (CAD).
OBJECTIVE
The aim of the article was to clarify whether the presence of Achilles tendon thickening (ATT) was associated with disease severity and plaque vulnerability in patients with CAD.
METHODS
A total of 241 consecutive patients who underwent percutaneous coronary intervention and ATT assessment were analyzed. ATT was defined as Achilles tendon thickness of ≥9 mm on radiograph. The severity of CAD and plaque vulnerability was assessed by the findings on angiogram and optical coherence tomography, respectively.
RESULTS
ATT was found in 44 patients (18.2%). The frequency of multivessel disease (79.6% vs 58.4%, P = .009) and left main lesion (13.6% vs 3.1%, P = .004) was significantly higher in patients with ATT (ATT group) than in patients without ATT (no ATT group). Multivariate logistic regression analyses demonstrated that the presence of ATT was independently associated with the presence of multivessel disease (odds ratio, 2.33; 95% confidence interval, 1.08-5.46; P = .031). The ATT group had a higher prevalence of intimal vascular channels (50.0% vs 24.7%, P = .018) and macrophage accumulation (58.3% vs 33.3%, P = .028) in culprit plaque than the no ATT group.
CONCLUSIONS
Patients with the presence of ATT had a higher prevalence of multivessel coronary disease and left main coronary artery disease than with patients without ATT. The presence of ATT was also associated with vulnerable features, including intimal vascular channels and macrophage accumulation in culprit plaques.

Identifiants

pubmed: 30472278
pii: S1933-2874(18)30427-6
doi: 10.1016/j.jacl.2018.10.007
pii:
doi:

Substances chimiques

Biomarkers 0
Cholesterol Esters 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

194-200

Informations de copyright

Copyright © 2018 National Lipid Association. Published by Elsevier Inc. All rights reserved.

Auteurs

Takuya Hashimoto (T)

Kitasato University Graduate School of Medical Sciences, Sagamihara, Japan.

Yoshiyasu Minami (Y)

Department of Cardiovascular Medicine, Kitasato University School of Medicine, Sagamihara, Japan. Electronic address: nrg12391@yahoo.co.jp.

Ryota Kakizaki (R)

Kitasato University Graduate School of Medical Sciences, Sagamihara, Japan.

Teruyoshi Nemoto (T)

Kitasato University Graduate School of Medical Sciences, Sagamihara, Japan.

Kazuhiro Fujiyoshi (K)

Kitasato University Graduate School of Medical Sciences, Sagamihara, Japan.

Kentaro Meguro (K)

Department of Cardiovascular Medicine, Kitasato University School of Medicine, Sagamihara, Japan.

Takao Shimohama (T)

Department of Cardiovascular Medicine, Kitasato University School of Medicine, Sagamihara, Japan.

Taiki Tojo (T)

Department of Cardiovascular Medicine, Kitasato University School of Medicine, Sagamihara, Japan.

Junya Ako (J)

Kitasato University Graduate School of Medical Sciences, Sagamihara, Japan; Department of Cardiovascular Medicine, Kitasato University School of Medicine, Sagamihara, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH